rs2498801

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The XR_429419.5(LOC102723342):​n.3057T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.406 in 196,072 control chromosomes in the GnomAD database, including 16,811 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 13251 hom., cov: 33)
Exomes 𝑓: 0.39 ( 3560 hom. )

Consequence

LOC102723342
XR_429419.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.18

Publications

16 publications found
Variant links:
Genes affected
AKT1 (HGNC:391): (AKT serine/threonine kinase 1) This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
AKT1 Gene-Disease associations (from GenCC):
  • Proteus syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden syndrome 6
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.614 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000649815.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKT1
NM_001382430.1
MANE Select
c.*1120A>G
downstream_gene
N/ANP_001369359.1B0LPE5
AKT1
NM_001014431.2
c.*1120A>G
downstream_gene
N/ANP_001014431.1B0LPE5
AKT1
NM_001014432.2
c.*1120A>G
downstream_gene
N/ANP_001014432.1P31749-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AKT1
ENST00000649815.2
MANE Select
c.*1120A>G
downstream_gene
N/AENSP00000497822.1P31749-1
AKT1
ENST00000349310.7
TSL:1
c.*1120A>G
downstream_gene
N/AENSP00000270202.4P31749-1
AKT1
ENST00000402615.6
TSL:1
c.*1120A>G
downstream_gene
N/AENSP00000385326.2P31749-1

Frequencies

GnomAD3 genomes
AF:
0.410
AC:
62230
AN:
151904
Hom.:
13243
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.470
Gnomad AMI
AF:
0.282
Gnomad AMR
AF:
0.473
Gnomad ASJ
AF:
0.308
Gnomad EAS
AF:
0.633
Gnomad SAS
AF:
0.543
Gnomad FIN
AF:
0.372
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.345
Gnomad OTH
AF:
0.398
GnomAD4 exome
AF:
0.392
AC:
17259
AN:
44052
Hom.:
3560
AF XY:
0.390
AC XY:
8149
AN XY:
20912
show subpopulations
African (AFR)
AF:
0.456
AC:
729
AN:
1600
American (AMR)
AF:
0.484
AC:
624
AN:
1288
Ashkenazi Jewish (ASJ)
AF:
0.308
AC:
805
AN:
2614
East Asian (EAS)
AF:
0.572
AC:
4140
AN:
7240
South Asian (SAS)
AF:
0.491
AC:
397
AN:
808
European-Finnish (FIN)
AF:
0.375
AC:
27
AN:
72
Middle Eastern (MID)
AF:
0.357
AC:
97
AN:
272
European-Non Finnish (NFE)
AF:
0.343
AC:
9132
AN:
26626
Other (OTH)
AF:
0.370
AC:
1308
AN:
3532
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
513
1025
1538
2050
2563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.410
AC:
62285
AN:
152020
Hom.:
13251
Cov.:
33
AF XY:
0.414
AC XY:
30755
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.471
AC:
19517
AN:
41470
American (AMR)
AF:
0.473
AC:
7229
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.308
AC:
1068
AN:
3470
East Asian (EAS)
AF:
0.632
AC:
3257
AN:
5152
South Asian (SAS)
AF:
0.542
AC:
2608
AN:
4812
European-Finnish (FIN)
AF:
0.372
AC:
3940
AN:
10580
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.345
AC:
23447
AN:
67942
Other (OTH)
AF:
0.400
AC:
845
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1859
3718
5576
7435
9294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
588
1176
1764
2352
2940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.384
Hom.:
1407
Bravo
AF:
0.418
Asia WGS
AF:
0.589
AC:
2048
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
2.9
DANN
Benign
0.41
PhyloP100
-1.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2498801; hg19: chr14-105235558; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.